ºZ¾P¦L«×·s«a¥é»sÃįA³y°²
ÀË´úµ²ªG¡G150¼Ë¥»8§t§í·s«a¯f¬r¦¨¤À ¾l¤U¶Èªv¬y·P

[2023.01.06] µoªí

¤º¦a·s«a¬Ì±¡ªï­«¯g°ª®p¡A³Q­«¯g±wªÌµø¬°¡u±Ï©RÃÄ¡vªº¬ü°ê½÷·ç·s«a¤fªAÃÄPaxlovid¤@ÃÄÃø¨D¡A¥Á²³¶i¦Ó´M¨D¦L«×¥é»sÃÄ¡A¨ä¤¤¡A³Ì¬°ºZ¾Pªººñ¦â¥]¸ËPrimovir(¡uºñ²°¡v)¤ÎÂŦâ¥]¸ËªºPaxista(¡uÂŲ°¡v)¡A¤wª£¨ì­ì»ùªº8­¿¥ª¥k¡A¤£¹L¦³·~¤º¤H¤hºÙ¡A¸gÃĪ«¦¨¤ÀÀË´ú¡A¦³¡uºñ²°¡vÃÄÅç¥X¨ÃµL¦³®Ä§í¨î·s«a¦¨¤À¡A¶È¦³¬y·PÃĪ«¦¨¤À¡A¯A¶û³y°²¡Cºî¦X³ø¹D

ºî¦X¡u¨C¤é¸gÀÙ·s»D¡v¡B¡m«n¤è³£¥«³ø¡nµ¥¤º¦a´CÅé³ø¹D¡A¥h¦~2¤ë11¤é¡A°ê®aÃĺʧ½À³«æªþ±ø¥ó§å­ã½÷·ç·s«a¤fªAÃÄPaxlovid(§Q¦«¨º­³©M©`º¿¯S­³²Õ¦¨ªº´_¦XÃÄ)¶i¤fµù¥U¡CPaxlovidªº©w»ù¬°2980¤¸(¤H¥Á¹ô¡A¤U¦P)¤@²°¡A¦b¬Ì±¡¤É·Åªº­I´º¤U¡A¦a¤U¥æ©ö¥«³õPaxlovid»ù®æ‘Cº¦¡C

½÷·çÃĶ¥«»ù‘C 1.6¸U¤@²°¤´ºò¯Ê

¤@¦W¤W®ü¥«¥Áªí¥Ü¡A¦oªñ´Á±q¶À¤û¤â¤¤¶R¨ì¤F¤@²°Paxlovid­ì¬ãÃÄ¡A»ù®æ¬°9500¤¸¡C

¦Ó¤º¦a°OªÌÁpô¤W¸Ó¦W¶À¤û®É¡A¨äªí¥Ü­ì¬ãÃļƶq«D±`ºò¯Ê¡A»ù®æ¬°1.5¸U¤¸¤@²°¡C¥t¾Ú«n³£³ø¹D¡A¦h¦WÃĪ«¥NÁÊ´£¨Ñªº³ø»ù¬°1¸U¤¸¥H¤W¡A¦³¶À¤û³ø»ù°ª¹F1.6¸U¤¸¡A¦ý¤´¨Ñ¤£À³¨D¡C

¦b¶R¤£¨ìPaxlovid­ì¬ãÃĪº±¡úG¤U¡A¤@¨Ç¥Á²³°h¦Ó¨DÁÊPaxlovidªº¦L«×¥é»sÃÄ¡C³Ìªñ¡A¦³¤£¤Öºô¥Áªí¥Ü¦bÁÊÃĮɾD¹J¶BÄF¡C

¡u¨C¤é¸gÀÙ·s»D¡v°OªÌ¥HÁÊÃĮ̄­¤ÀÁpô¤@¦WÃÄ«~¥NÁÊ¡A¹ï¤èªí¥Ü¤â¤W¦³¡uºñ²°¡v(Primovir)©M¡uÂŲ°¡v(Paxista)¨âºØ¥é»sÃÄ¡A¨ä¤¤¡uºñ²°¡v2500¤¸¤@²°¡A¡uÂŲ°¡v2700¤¸¤@²°¡A¦ý§¡µL²{³f¡A­n¥I´Ú3¦Ü7¤Ñ«á¤~¯àµo³f¡C¨äªí¥Ü¡A¡u²{³f¤@¨ì°ê¤º¥ß§Y´Nµo¥ú¤F¡v¡C

¥t¤@¦W¥NÁʦP¼Ëªí¥Ü¨S¦³²{³f¡A¥u±µ¨ü¹w­q¡uºñ²°¡v¡C¡uÂŲ°¡vªº»ù®æ¡A¤w½æ¨ì¤F¤@²°1.5¸U¤¸¡C¡uºñ²°¡v©M¡uÂŲ°¡v³£¬OPaxlovidªº¥é»sÃÄ¡AÃÄ«~¥]¸Ë²°¤Wªº¸ê®ÆÅã¥Ü¡A¡uÂŲ°¡v¥Ñ¦L«×®ü¼wÀs¤l¤½¥qªü´µ¶ðAzista¤½¥q»s³y¡F¡uºñ²°¡vªº¥]¸Ë²°¤W¶È¼g¤F¥ÑAstrica Health Care¤½¥q­t³d¾P°â¡C

¥Á²³ÂàÁʦL«×¥é»sÃÄ »ùªñ­ì¬ãÃÄ

¥NÁÊ¡GÂŲ°ºñ²°§¡µL²{³f

¹ï©ó¥é»sÃÄ¡AµØ¤j°ò¦]­º®u°õ¦æ©x¤¨êMªñ¤é¦b¨ä·L«H¤½²³¸¹µo¤åºÙ¡A¡u¦³¦L«×¥é»sÃĥΪvÀø¬y·PªºÃĪ«¡A°½´«¤F§í¨î·s«a¯f¬rªºÃĪ«¡v¡C¤¨êMªí¥Ü¡A¦Ü¬Q±ß8®É¡AµØ¤j½èÃйζ¤²Ö­p§¹¦¨150­Ó¥é»sÃļ˥»ÀË´ú¡A¨ä¤¤8¥÷ÀË¥X§í¨î·s«a¯f¬r¦b¤HÅ餺¼W´Þªº©`º¿¯S­³(Nirmatrelvir)¡A¨ä¾l«h¶È§t§Ü¬y·PÃĪ«¶ø¥q¥L­³(Oseltamivir)¡C¤¨êM´£¿ôºô¥ÁÁʶR¡uºñ²°¡v¶··V­«¡C·L³Õ³Õ¥D¡u³Í³ß³Õ¤hDrCash¡v¥ç©óªñ¤éÀË´ú¤F14­Ó¡uºñ²°¡v¼Ë¥»¡A¨ä¤¤¥u¦³1­Ó§t¦³©`º¿¯S­³¡C

¦LÃÄ¥ø¡G¥N¤u¼t³g°ý ¥Í²£µL®ÄÃÄ

¤W®ü³ø·~¶°¹ÎºX¤Uªº¡m¬ì³ÐªO¤é³ø¡n¬Q¤Þ­z¯A¨Æ¦L«×ÃÄ¥øAstrica¬ÛÃö­t³d¤Hªí¥Ü¡A¬O¥N¤u¼t¤Ó³g°ý¡A¥Í²£¤F¤£§t©`º¿¯S­³­ì®ÆÃĪºµL®ÄprimovirÃÄ«~¡C

§ó¦h¤¤°ê­n»D
¡i©ú³ø±M°T¡jµá«ß»«Á`²Î¤p°¨¥i´µ¡]Ferdinand Marcos Jr.¡^©P¥|¡]5¤é¡^µ²§ô¹ï¤¤°ê°ê¨Æ³X°Ý¡A¨Ã­¼±M¾÷ªð©è°¨¥§©Ô¡A¥L¦bºû©Ô²öªÅ­x... ¸Ô±¡
¡i©ú³ø±M°T¡j¤¤°ê¥~¥æ³¡ªø¯³­è©ó·í¦a®É¶¡©P¤T¡]4¤é¡^¦b¡mµØ²±¹y¶l³ø¡nµoªíÃD¬°¡qí©wªº¤¤¬üÃö«Y§ñÃö§Ú­Ì¬P²yªº«e³~©R¹B¡rªº¤å³¹¡A°í«H¤¤¬üÃö«Yªº¤jªù... ¸Ô±¡
¡i©ú³ø±M°T¡j¥_¨Ê¥«¥ÍºAÀô¹Ò§½©P¤T¤½¥¬2022¦~¥_¨Ê¥«¤j®ðÀô¹Ò¤¤·L²ÓÄa¯B²É¤l¡]PM2.5¡^¼Æ¾Ú¡C·í¦a³sÄò¨â¦~¹F¨ì°ê®aªÅ®ð½è¶q¤G¯Å¼Ð·Ç¡A¦~§¡¿@«×... ¸Ô±¡
¡i©ú³ø±M°T¡jªe¥_¦h¦a¿U®ð¨ÑÀ³°Ó¤¤¿U¤½¥qªñ´Á³Q§ë¶DÀWÁc¥X²{¤ÑµM®ð­­ÁÊ¡B¤£©w®É°±®ð¡B¿U®ð½è¶q¤U­°µ¥°ÝÃD¡C²{®Éªe¥_©]¶¡®ð·Å§C¨£¹s¤U14¢J¡A­P·í¦a¹L... ¸Ô±¡
¡i©ú³ø±M°T¡jºÖ«Ø¬Ù·Hªù¥«¤¤¯Å¤H¥Áªk°|¬Q¤@¼f¤½¶}¶}®x¼f²z¤F­ì°ê®a³­¹§½°Æ§½ªø®}»ï¡]¹Ï¡^¨ü¸ì¡B§Q¥Î¼vÅT¤O¨ü¸ì¤@®×¡C®}³Q«ü±±¦b1995¦~¦Ü2021... ¸Ô±¡

©ú³øºô¯¸ ¡P ª©Åv©Ò¦³ ¡P ¤£±oÂà¸ü
Copyright © 2023 mingpaocanada.com All rights reserved.
Ming Pao Daily News A wholly owned subsidiary of Ming Pao Enterprise Corporation Ltd.
Toronto Chinese Newspaper

Chief Executive Officer: Ka Ming Lui | Executive Chief Editor: Richard Kwok Kai Ng
1355 Huntingwood Drive, Scarborough, Ontario, Canada M1S 3J1 | Tel.: (416) 321-0088 | Fax: (416) 321-5377 | Advertising Hotline Tel: (416) 673-8250